 If more than one DLT occurs among the three or six evaluable patients included in the 1st cohort, an alternative dose escalation will be started, with a reduction of the dose of pomalidomide see Figure 1. Patients will be then treated following again the same 33 algorithm. If more than one DLT out of three or six patients occur at the first dose level of the alternative escalation, the study will be stopped. 